Felicity Thomas

Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.

Opportunities and developments in particle engineering are providing developers with the tools to advance drug candidates successfully.

Industry and the government must work closely to ensure the UK remains a competitor in the clinical research field.

In this episode, Ana Ladino provides expert insight into novel excipients in the current and future drug development landscape.

Pharmaceutical Technology editors interview oral solid dosage development experts from Syntegon and Colorcon, with discussions centered on continuous OSD production, containment safety, and authentication at the dose level.

External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Pharmaceutical Technology Europe pays tribute to the role Her Majesty Queen Elizabeth II had in promoting innovation within life sciences.

It is possible to overcome some of the limitations of traditional dosage forms by employing alternative drug delivery formulation strategies.

As winter approaches, the next generation of COVID-19 vaccines are being prepared and scheduled, ready for distribution across Europe and the world.

Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Industry is adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline.

Automated finished product inspection has been widely adopted in the bio/pharmaceutical industry.

In this episode, Fernando Muzzio provides greater insight into a novel approach to improving drug solubility—continuous melt coating.

GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.

In this episode, experts share their insights into important drug packaging advances of the past, present, and future.

To ensure patient safety, drug products must be tested for elemental impurities that pose risk.

Technological advances are progressing pharmaceutical packaging to overcome the challenges of the future.

Biologics are forming a greater proportion of the development pipeline, but there are still some formulation difficulties to overcome to ensure clinical and commercial success.

Dame Deborah James’ legacy and the millions raised through her campaigning will undoubtedly be a big boost to clinical research, ultimately providing new and promising treatments for bowel cancer patients.

Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.

Analyzing elemental impurities in drug products is—much like other analytical testing—primarily aimed at ensuring patient safety.

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Cases of monkeypox are rising around the world, but it is unlikely the virus will become a pandemic problem.

In this episode of Drug Digest, Pharmaceutical Technology editors, Felicity Thomas and Feliza Mirasol, examine the topic of emerging therapies in more detail, covering subjects such as the challenges of scale, the potential benefits of drug delivery innovation, importance of early analytical studies, the evolution of the regulatory landscape, and differences between regional regulatory requirements.

Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.

Partnering with an experienced service provider can help companies unlock the commercial potential of new therapeutic approaches.

A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.

The challenges of conducting protein characterization can be overcome through the use of technologies that empower scientists in their analytical work.

An early formulation strategy for tablets that is simple and scalable is recommended to ensure fewer downstream problems.